| Li, Rui |
NCT05058040: A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971) |
|
|
| Active, not recruiting | 4 | 2500 | RoW | Sodium Oligomannate Capsules | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Alzheimer Disease | 01/25 | 04/25 | | |
NCT05003245: Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMD |
|
|
| Recruiting | 3 | 388 | RoW | HLX04-Oļ¼recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection, Lucentis | Shanghai Henlius Biotech | Age Related Macular Degeneration | 08/23 | 03/24 | | |
| Recruiting | 3 | 1200 | Europe, Canada, Japan, US, RoW | Remternetug, LY3372993, Placebo | Eli Lilly and Company | Alzheimer's Disease | 04/29 | 10/30 | | |
CA209-8H3, NCT03650894: Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients |
|
|
| Active, not recruiting | 2 | 30 | US | Nivolumab, Opdivo, Ipilimumab, Yervoy, Bicalutamide, Casodex | Providence Health & Services, Bristol-Myers Squibb, Memorial Sloan Kettering Cancer Center | Breast Neoplasm Female, Breast Cancer, Breast Carcinoma, Breast Tumor | 01/25 | 01/26 | | |
NCT06353997: Neoadjuvant INBRX-106 (Hexavalent OX40 Agonist) in Combination With Pembrolizumab as a Chemotherapy-sparing Regimen for Stage II TNBC (Triple Negative Breast Cancer) Patients |
|
|
| Recruiting | 2 | 12 | US | Pembrolizumab, KEYTRUDA, INBRX-106 | Providence Health & Services, Inhibrx Biosciences, Inc | Triple Negative Breast Cancer | 06/27 | 06/29 | | |
NCT04922593: Relative Bioavailability of LY03010 Compared to Listed Drug |
|
|
| Completed | 1 | 281 | US | LY03010; paliperidone palmitate, INVEGA SUSTENNA | Luye Pharma Group Ltd. | Schizophrenia, Psychotic Disorders, Mood Disorders, Schizophrenia Spectrum, Mental Disorders, Antipsychotic Agents, Tranquilizing Agents, Central Nervous System Depressants, Physiological Effects of Drugs, Psychotropic Drugs, Neurotransmitter Agents, Molecular Mechanisms of Pharmacological Action | 03/22 | 04/22 | | |
NCT05321602: Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder |
|
|
| Completed | 1 | 89 | US | LY03010 156 mg treatment group, deltoid, paliperidone palmitate, LY03010 156 mg treatment group, gluteal, LY03010 351 mg treatment group, deltoid, LY03010 351 mg treatment group, gluteal | Luye Pharma Group Ltd. | Schizophrenia, Psychotic Disorders, Mood Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, Mental Disorders, Antipsychotic Agents, Tranquilizing Agents, Central Nervous System Depression, Physiological Effects of Drugs, Psychotropic Drugs, Neurotransmitter Agents, Molecular Mechanisms of Pharmacological Action | 09/22 | 10/22 | | |
NCT04895761: Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer |
|
|
| Active, not recruiting | 1 | 6 | US | DPX-Survivac, Letrozole 2.5mg, Femara, Cyclophosphamide 50mg, cytoxan, XRT 10Gy x2 | Providence Health & Services | Breast Cancer | 06/23 | 09/26 | | |
NCT06409078: Repeated Transcranial Magnetic Stimulation Relieve Chronic Visceral Pain in IBS |
|
|
| Recruiting | 1 | 200 | RoW | repeated transcranial magnetic stimulation treatment group, transcranial magnetic stimulation, Western medicine group, Pivoxyl Bromide Tablets | The First Affiliated Hospital of Soochow University, Soochow University | Irritable Bowel Syndrome, Repetitive Transcranial Magnetic Stimulation, Chronic Visceral Pain, Functional Magnetic Resonance Imaging | 01/26 | 01/26 | | |
NCT05249114: Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors |
|
|
| Active, not recruiting | 1 | 6 | US | Cabozantinib, Cabometyx, Lu-177, Lutathera | Providence Health & Services, Exelixis, Advanced Accelerator Applications SA | Neuroendocrine Tumors | 12/24 | 12/26 | | |
NCT06321614: Deep Learning in Classifying Bowel Obstruction Radiographs |
|
|
| Active, not recruiting | N/A | 4500 | RoW | | The First Affiliated Hospital of Soochow University | Digestive System Disease, Polyp of Colon, Bowel Disease | 04/24 | 12/24 | | |
NCT03748563: Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis |
|
|
| Completed | N/A | 607 | RoW | ds-MCE and EGD | Changhai Hospital, Ruijin Hospital, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai East Hospital of Tongji University, Yangpu District Central Hospital Affiliated to Tongji University, Zhujiang Hospital, Qilu Hospital of Shandong University, The Third Xiangya Hospital of Central South University, First Affiliated Hospital Xi'an Jiaotong University, Wuhan Union Hospital, China, The Fifth Affiliated Hospital of Zunyi Medical College, The First Affiliated Hospital of Zhejiang Chinese Medical University, Shanghai Pudong New Area Gongli Hospital | Liver Cirrhosis, Portal Hypertension, Esophageal Varices, Gastric Varix | 01/23 | 03/23 | | |
NCT06182917: Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients |
|
|
| Recruiting | N/A | 35 | RoW | | West China Second University Hospital | Ovarian Cancer | 12/25 | 06/26 | | |
NCT06031363: The Optimal Dose of Indomethacin Suppository for Preventing Post-ERCP Pancreatitis |
|
|
| Completed | N/A | 192 | RoW | Indomethacin Suppository, Indomethacin | The First Affiliated Hospital of Soochow University | Pancreatitis, Cholangiopancreatography, Endoscopic Retrograde, Indomethacin | 12/23 | 01/24 | | |
| Active, not recruiting | N/A | 100 | RoW | repeated transcranial magnetic stimulation treatment | The First Affiliated Hospital of Soochow University | Repetitive Transcranial Magnetic Stimulation, Chronic Visceral Pain, Functional Magnetic Resonance Imaging, IBS (Irritable Bowel Syndrome), Clinical Efficacy | 01/26 | 01/26 | | |
